Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.360
-0.220 (-4.80%)
Dec 5, 2025, 4:00 PM EST - Market closed
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts that cover Foghorn Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $11.86, which forecasts a 172.02% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $14.
Price Target: $11.86 (+172.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 6 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +175.23% | Dec 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +175.23% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +106.42% | May 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +106.42% | Apr 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +198.17% | Apr 30, 2025 |
Financial Forecast
Revenue This Year
33.34M
from 22.60M
Increased by 47.50%
Revenue Next Year
32.76M
from 33.34M
Decreased by -1.74%
EPS This Year
-1.13
from -1.58
EPS Next Year
-1.17
from -1.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 49.0M | 52.5M | ||||
| Avg | 33.3M | 32.8M | ||||
| Low | 26.2M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 116.8% | 57.5% | ||||
| Avg | 47.5% | -1.7% | ||||
| Low | 15.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.96 | -0.77 | ||||
| Avg | -1.13 | -1.17 | ||||
| Low | -1.28 | -1.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.